SCI & TECH● LOW1h ago · Oct 5, 2026, 2:53 PM
Vaxcyte jumps on phase 3 data for pneumonia vaccine VAX-31
Seeking Alpha Tech · global
Vaxcyte stock has risen following positive phase 3 data for its pneumonia vaccine, VAX-31. This development indicates potential progress in a new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH13m agoNew map exposes dire state of American rivers as only six percent are healthy amid climate emergencyThe Independent WorldSCI & TECH42m agoAI cannot replace Nigerian teachers – AlausaVanguard NigeriaSCI & TECH1h agoExtinct yak relative discovered from DNA in Denisova caveNew ScientistSCI & TECH1h agoAI finds bafflingly complex but beautiful symmetrical Venn diagramNew Scientist